MYELOMA MULTIPLE
Clinical trials for MYELOMA MULTIPLE explained in plain language.
Never miss a new study
Get alerted when new MYELOMA MULTIPLE trials appear
Sign up with your email to follow new studies for MYELOMA MULTIPLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to restore kidneys in myeloma patients
Disease control OngoingThis study tests whether adding daratumumab to standard treatment (bortezomib and dexamethasone) can improve kidney function better than the usual approach (cyclophosphamide, bortezomib, and dexamethasone) in people newly diagnosed with multiple myeloma who also have kidney failu…
Matched conditions: MYELOMA MULTIPLE
Phase: PHASE2 • Sponsor: Eastern Cooperative Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New Shot-Based combo aims to ease myeloma treatment burden
Disease control OngoingThis study tests a new way to give a drug called isatuximab as a quick shot under the skin, instead of a long IV drip, for people newly diagnosed with multiple myeloma who cannot have a stem cell transplant. The shot is combined with three standard chemotherapy drugs. The goal is…
Matched conditions: MYELOMA MULTIPLE
Phase: NA • Sponsor: Poitiers University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New drug cocktail shows promise for myeloma patients ineligible for transplant
Disease control OngoingThis study tests a combination of four drugs (lenalidomide, ixazomib, dexamethasone, and daratumumab) in 79 adults newly diagnosed with multiple myeloma who cannot have a stem cell transplant. Participants receive the drugs for 12 cycles, then are split into two groups: one conti…
Matched conditions: MYELOMA MULTIPLE
Phase: PHASE2 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC